3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
26
Neoplasm Metastasis
7
Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Advanced Solid Tumors
2
Thyroid Neoplasms
1
Recurrence Free Survival
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Histiocytosis
1
Glioma
1
Fallopian Tube Neoplasms
1
Erythema
1
Endometrial Neoplasms
1
Edema
1
Dihydropyrimidine Dehydrogenase Deficiency
1
Colorectal Cancer Metastatic
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
32
Cisplatin
31
durvalumab
15
pembrolizumab
14
Fluorouracil
13
Oxaliplatin
12
Leucovorin
12
Capecitabine
10
Bevacizumab
8
lenvatinib
7
Nivolumab
7
zanidatamab
4
Trastuzumab
4
S 1 (combination)
4
Paclitaxel
4
Liquid Biopsy
4
Irinotecan
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
tremelimumab
3
tislelizumab
3
irinotecan sucrosofate
3
Injections
3
Folfox protocol
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
pertuzumab
2
niraparib
2
ivosidenib
2
envafolimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Panitumumab
×
1 year
×
Clear all
No trials found.